These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1585407)
1. Effect of food on salsalate absorption. Harrison LI; Riedel DJ; Armstrong KE; Goldlust MB; Ekholm BP Ther Drug Monit; 1992 Apr; 14(2):87-91. PubMed ID: 1585407 [TBL] [Abstract][Full Text] [Related]
2. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults. Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of salsalate in normal subjects. Dromgoole SH; Furst DE; Paulus HE J Pharm Sci; 1984 Nov; 73(11):1657-9. PubMed ID: 6520777 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
5. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials. Godfrey AR; Digiacinto J; Davis MW Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study. Sikes C; Stark JG; McMahen R; Engelking D Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216 [TBL] [Abstract][Full Text] [Related]
7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
8. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone. Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146 [TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
10. Availability of salicylate from salsalate and aspirin. Dromgoole SH; Cassell S; Furst DE; Paulus HE Clin Pharmacol Ther; 1983 Oct; 34(4):539-45. PubMed ID: 6617077 [TBL] [Abstract][Full Text] [Related]
11. Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption. Yuen GJ; Lou Y; Thompson NF; Otto VR; Allsup TL; Mahony WB; Hutman HW J Clin Pharmacol; 2001 Mar; 41(3):277-88. PubMed ID: 11269568 [TBL] [Abstract][Full Text] [Related]
12. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study. Scallion R; Moore KA Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894 [TBL] [Abstract][Full Text] [Related]
14. Influence of food intake on the pharmacokinetics of avosentan in man. Dieterle W; Hengelage T Int J Clin Pharmacol Ther; 2008 Sep; 46(9):453-8. PubMed ID: 18793575 [TBL] [Abstract][Full Text] [Related]
15. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast. Schug BS; Brendel E; Wonnemann M; Wolf D; Wargenau M; Dingler A; Blume HH Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144 [TBL] [Abstract][Full Text] [Related]
16. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet. Erdman K; Stypinski D; Combs M; Witt P; Stiles M; Pollock S Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate. Lambrecht LJ; Shekh-Ahmad T; Todd WM; Halvorsen MB; Bialer M Epilepsia; 2011 Oct; 52(10):1877-83. PubMed ID: 21770925 [TBL] [Abstract][Full Text] [Related]
18. Effect of food on the pharmacokinetics of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in healthy subjects. Ge J; Ding LK; Yang J; Jia YY; Lu CT; Ding Y; Song Y; Song W; Wen AD Int J Clin Pharmacol Ther; 2015 Mar; 53(3):272-6. PubMed ID: 25546165 [TBL] [Abstract][Full Text] [Related]
19. Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis. Williams ME; Weinblatt M; Rosa RM; Griffin VL; Goldlust MB; Shang SF; Harrison LI; Brown RS Clin Pharmacol Ther; 1986 Apr; 39(4):420-4. PubMed ID: 3956057 [TBL] [Abstract][Full Text] [Related]
20. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults. Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]